Stay updated on FG-4592 and Rosiglitazone Interaction Clinical Trial
Sign up to get notified when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.

Latest updates to the FG-4592 and Rosiglitazone Interaction Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 was applied; there are no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1; this is a minor maintenance update that does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedKyntra Bio is now listed as sponsor, and FibroGen is no longer listed as sponsor.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page shows a minor revision from v3.3.3 to v3.3.4 with no observable changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedFooter/site-wide updates include the addition of 'Revision: v3.3.3' and the removal of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'; these changes do not affect the study page content or its data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision label in the page footer updated from v3.2.0 to v3.3.2 as part of a platform update; no changes to study details or primary content.SummaryDifference0.1%

Stay in the know with updates to FG-4592 and Rosiglitazone Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.